Utility of Intermediate Care Units: A Systematic Review Study.

Publication date: Jan 24, 2024

Intermediate care units (IMCUs) have become increasingly important in the care of critical and semi-critical patients, particularly during the COVID-19 pandemic. However, there is still no clear definition of their structural characteristics, specialties, types of patients, and the benefits they provide. The aim of this work is to describe the current state of implementation and operation of IMCUs in hospitals and patient care. To achieve this goal, a systematic review was conducted in the Web of Science, Scopus and CINAHL databases, along with a hand search. The research yielded 419 documents, of which 26 were included in this review after applying inclusion and exclusion criteria. The results were highly diverse and were categorized based on the following topics: material resources, human resources, continuity of care, and patient benefits. Despite the different objectives outlined in the studies, all of them demonstrate the numerous benefits provided by an IMCU, along with the increased relevance of this type of unit in recent years. Therefore, this systematic review highlights the benefits of IMCUs in the care of critical patients, as well as the role of health workers in these units.

Open Access PDF

Concepts Keywords
Basel benefits
Databases effectiveness
Healthcare intensive medicine
Increased intermediate care facilities
Pandemic intermediate care units
patient comfort

Semantics

Type Source Name
disease MESH COVID-19 pandemic
disease VO effectiveness
drug DRUGBANK Tretamine
disease MESH critically ill
disease IDO quality
drug DRUGBANK Coenzyme M
drug DRUGBANK Azelaic acid
disease MESH emergency
drug DRUGBANK Aspartame
drug DRUGBANK Etoperidone
disease VO organization
disease VO efficient
disease VO protocol
disease IDO process
disease VO time
disease IDO country
disease VO Canada
disease MESH morbidity
disease VO efficiency
disease VO Equity
disease VO USA
disease MESH respiratory failure
disease MESH pneumonia
disease MESH educational status
disease VO population
disease VO frequency
disease VO volume
disease MESH postoperative complications
disease VO effective
disease VO Gap
disease MESH complications
disease VO organ
drug DRUGBANK Methyl isocyanate
drug DRUGBANK L-Aspartic Acid
disease IDO facility
drug DRUGBANK Ilex paraguariensis leaf

Original Article

(Visited 2 times, 1 visits today)